Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Shimadzu allies with CiRA on stem cell research

Shimadzu allies with CiRA on stem cell research

23rd February 2011

Shimadzu is to collaborate with the Kyoto University Center for iPS Cell Research and Application (CiRA) on new research into stem cells.

Under the terms of the collaborative research agreement, Shimadzu will utilise its mass spectrometry advances to analyse the reprogramming states and potential biomarkers in induced pluripotent stem cells (iPSCs).

CiRA, which was created in 2007 and has operated independently since April last year, will be responsible for manufacturing the iPSCs used in the research.

Via comparative analysis of cell properties and gene expression pattern, it is hoped that novel biomarkers such as DNA, RNA, small peptides and protein fragments can be isolated.

A statement from Shimadzu added: "This research may lead to techniques for the selection of more fully reprogrammed pluripotent cells and of higher quality target cells in induced differentiation protocols."

Earlier this month, the science company launched its TOC-L Series of combustion catalytic oxidation total organic carbon analysers, which can be used in pharmaceutical water management.ADNFCR-8000103-ID-800423359-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.